Click below for our latest newsletter.

Start-up Australia is a specialist venture capital company which invests in innovative life science companies. These companies may operate in a range of sectors including; human health, animal health, agritech and environmental technology.

Start-up Australia has a track record of delivering attractive financial returns to our investors.

Latest News

BNC210 anti-anxiety clinical data presented at Neuroscience 201.

US market launch of Alchemia's fondaparinux.

FDA approves Alchemia's fondaparinux.

Results of Bionomics' cancer drug clinical trial published.

Merck extends Multiple Sclerosis collaboration with Bionomics.

Bionomics raises $14.25 million.

Start-up Australia sells 60 million shares in Bionomics to institutions.

Independent study - further validation of BNC210 (anti-anxiety drug).

Bionomics investor presentation.

Bionomics presents data at AACR conference.

Start-up terminates tender process for Bionomics.

Bionomics announces successful clinical results for anxiety drug.

Ironwood Pharmaceuticals and Protagonist establish collaboration.